Falcon Point Capital LLC lowered its position in shares of MAXIMUS, Inc. (NYSE:MMS) by 4.1% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 33,789 shares of the health services provider’s stock after selling 1,456 shares during the period. Falcon Point Capital LLC’s holdings in MAXIMUS were worth $2,398,000 at the end of the most recent reporting period.
Other hedge funds have also recently made changes to their positions in the company. Oregon Public Employees Retirement Fund boosted its position in shares of MAXIMUS by 6,329.9% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 1,656,085 shares of the health services provider’s stock valued at $25,000 after purchasing an additional 1,630,329 shares during the period. Norges Bank acquired a new position in shares of MAXIMUS in the 4th quarter valued at $49,088,000. Virginia Retirement Systems ET AL boosted its position in shares of MAXIMUS by 1,483.2% in the 1st quarter. Virginia Retirement Systems ET AL now owns 310,300 shares of the health services provider’s stock valued at $22,025,000 after purchasing an additional 290,700 shares during the period. Mackenzie Financial Corp boosted its position in shares of MAXIMUS by 17.6% in the 4th quarter. Mackenzie Financial Corp now owns 1,853,213 shares of the health services provider’s stock valued at $120,626,000 after purchasing an additional 277,775 shares during the period. Finally, Ranger Investment Management L.P. lifted its stake in MAXIMUS by 113.2% in the 4th quarter. Ranger Investment Management L.P. now owns 467,032 shares of the health services provider’s stock worth $30,399,000 after acquiring an additional 248,002 shares in the last quarter. 95.81% of the stock is owned by institutional investors and hedge funds.
A number of equities research analysts have recently weighed in on MMS shares. Zacks Investment Research raised MAXIMUS from a “hold” rating to a “buy” rating and set a $78.00 price target for the company in a research note on Tuesday, February 12th. ValuEngine downgraded MAXIMUS from a “buy” rating to a “hold” rating in a research note on Thursday, February 28th.
MMS opened at $71.49 on Monday. MAXIMUS, Inc. has a fifty-two week low of $60.00 and a fifty-two week high of $74.18. The company has a debt-to-equity ratio of 0.06, a current ratio of 2.31 and a quick ratio of 2.31. The stock has a market cap of $4.56 billion, a PE ratio of 21.03, a PEG ratio of 1.93 and a beta of 0.96.
MAXIMUS (NYSE:MMS) last posted its quarterly earnings results on Thursday, May 9th. The health services provider reported $0.96 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.91 by $0.05. MAXIMUS had a return on equity of 21.19% and a net margin of 8.76%. The company had revenue of $736.50 million during the quarter, compared to the consensus estimate of $757.29 million. During the same period last year, the business earned $0.84 EPS. The business’s quarterly revenue was up 20.2% on a year-over-year basis. On average, research analysts forecast that MAXIMUS, Inc. will post 3.71 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, May 31st. Shareholders of record on Wednesday, May 15th will be issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 1.40%. The ex-dividend date is Tuesday, May 14th. MAXIMUS’s dividend payout ratio (DPR) is currently 29.41%.
MAXIMUS Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.
Featured Story: How to Invest in Growth Stocks
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.